scholarly article | Q13442814 |
P356 | DOI | 10.1017/CJN.2019.287 |
P698 | PubMed publication ID | 31452470 |
P2093 | author name string | Stephen Joza | |
Richard Camicioli | |||
Fang Ba | |||
P2860 | cites work | Imagined gait modulates neuronal network dynamics in the human pedunculopontine nucleus | Q21147053 |
Occupational therapy for patients with Parkinson's disease | Q24243925 | ||
Second consensus statement on the diagnosis of multiple system atrophy | Q24650965 | ||
Brainstem control of locomotion and muscle tone with special reference to the role of the mesopontine tegmentum and medullary reticulospinal systems | Q26779826 | ||
Cognitive Impairment in Fall-Related Studies in Parkinson's Disease | Q26781116 | ||
Gait and cognition: a complementary approach to understanding brain function and the risk of falling | Q26992286 | ||
Effect of rhythmic auditory stimulation on gait in Parkinsonian patients with and without freezing of gait | Q27333088 | ||
Arguing against the proposed definition changes of PD | Q28079237 | ||
Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression | Q28211928 | ||
The dopaminergic response in multiple system atrophy | Q28317869 | ||
Risk of Injurious Fall and Hip Fracture up to 26 y before the Diagnosis of Parkinson Disease: Nested Case-Control Studies in a Nationwide Cohort | Q28601487 | ||
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium | Q29614409 | ||
Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease | Q30248491 | ||
Training in mental singing while walking improves gait disturbance in Parkinson's disease patients. | Q30371707 | ||
Effects of dual-task cognitive-gait intervention on memory and gait dynamics in older adults with a history of falls: a preliminary investigation. | Q30375924 | ||
Fall frequency and risk assessment in early Parkinson's disease | Q30418009 | ||
A randomised controlled trial evaluating the effect of an individual auditory cueing device on freezing and gait speed in people with Parkinson's disease | Q30491636 | ||
Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients | Q30688673 | ||
Highly Challenging Balance Program Reduces Fall Rate in Parkinson Disease | Q30689523 | ||
Falls documentation in nursing homes: agreement between the minimum data set and chart abstractions of medical and nursing documentation | Q30981444 | ||
Protocol for a home-based integrated physical therapy program to reduce falls and improve mobility in people with Parkinson's disease | Q31073422 | ||
Associations between quantitative mobility measures derived from components of conventional mobility testing and Parkinsonian gait in older adults | Q31148852 | ||
Carotid sinus syndrome: a modifiable risk factor for nonaccidental falls in older adults (SAFE PACE). | Q33147006 | ||
Neurocardiovascular instability in cognitive impairment and dementia. | Q33148401 | ||
Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study. | Q33157400 | ||
Health and social status in patients with hip fractures and controls. | Q52077699 | ||
The role of the prefrontal cortex in freezing of gait in Parkinson's disease: insights from a deep repetitive transcranial magnetic stimulation exploratory study. | Q52094852 | ||
Freezing of gait: Promising avenues for future treatment. | Q52351816 | ||
Cardiovascular effects of levodopa in Parkinson's disease. | Q52877002 | ||
Outcomes from stimulation of the caudal zona incerta and pedunculopontine nucleus in patients with Parkinson's disease. | Q53048676 | ||
Visual perception in Parkinson disease dementia and dementia with Lewy bodies. | Q53266135 | ||
The prevalence, assessment and associations of falls in dementia with Lewy bodies and Alzheimer's disease. | Q53333743 | ||
Task- and Context-Specific Balance Training Program Enhances Dynamic Balance and Functional Performance in Parkinsonian Nonfallers: A Randomized Controlled Trial With Six-Month Follow-Up. | Q53375813 | ||
Effect of cognitive remediation on gait in sedentary seniors. | Q53464045 | ||
Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study | Q56379583 | ||
Gait characteristics and falls in Parkinson's disease: A systematic review and meta-analysis | Q57175702 | ||
The period of hypotension following orthostatic challenge is prolonged in dementia with Lewy bodies | Q57675853 | ||
Cardiovascular autonomic neuropathy and falls in Parkinson disease: a prospective cohort study | Q58089131 | ||
Falls in people with Parkinson’s disease: A prospective comparison of community and home-based falls | Q60596736 | ||
DATATOP: A decade of neuroprotective inquiry | Q61773227 | ||
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: From the advanced phase towards the late stage of the disease? | Q61866746 | ||
Freezing of gait and dementia in parkinsonism: A retrospective case-control study. | Q64767162 | ||
Dyskinesia and FAB score predict future falling in Parkinson's disease | Q64778280 | ||
Clinical and anatomical predictors for freezing of gait and falls after subthalamic deep brain stimulation in Parkinson's disease patients | Q64781384 | ||
Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease | Q64785442 | ||
Age and time course of long-term motor and nonmotor complications in Parkinson disease | Q64791301 | ||
Clinical and physiological assessments for elucidating falls risk in Parkinson's disease | Q64813508 | ||
Progression of falls in postmortem-confirmed parkinsonian disorders | Q64819962 | ||
What predicts falls in Parkinson disease?: Observations from the Parkinson's Foundation registry | Q64863539 | ||
What is the therapeutic mechanism of pedunculopontine nucleus stimulation in Parkinson's disease? | Q64866531 | ||
A Prospective Evaluation of an Outpatient Assessment of Postural Instability to Predict Risk of Falls in Patients with Parkinson's Disease Presenting for Deep Brain Stimulation. | Q64882629 | ||
The circumstances of falls among people with Parkinson's disease and the use of Falls Diaries to facilitate reporting. | Q67223294 | ||
Individual manifestations of Parkinson's disease after ten or more years of levodopa | Q68843301 | ||
Falls in dementia patients | Q70647824 | ||
Fall-related injuries in dementia with Lewy bodies (DLB) and Alzheimer's disease | Q73789704 | ||
Comparison of extrapyramidal signs in dementia with Lewy bodies and Parkinson's disease | Q74404703 | ||
Effects of visual and auditory cues on gait in individuals with Parkinson's disease | Q79838120 | ||
Effects of subthalamic nucleus stimulation and levodopa on freezing of gait in Parkinson disease | Q81087805 | ||
Impaired attention predicts falling in Parkinson's disease | Q81296688 | ||
Bilateral subthalamic nucleus stimulation for Parkinson's disease: a systematic review of the clinical literature | Q81568359 | ||
Risk factors for frequent falls in people with Parkinson's disease | Q85656149 | ||
Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants | Q33159140 | ||
Dementia medications and risk of falls, syncope, and related adverse events: meta-analysis of randomized controlled trials. | Q33160127 | ||
Etiology of Syncope and Unexplained Falls in Elderly Adults with Dementia: Syncope and Dementia (SYD) Study | Q33167349 | ||
Interventions for the prevention of falls in older adults: systematic review and meta-analysis of randomised clinical trials | Q33199828 | ||
Incidence and prediction of falls in dementia: a prospective study in older people | Q33444673 | ||
Objective assessment of fall risk in Parkinson's disease using a body-fixed sensor worn for 3 days | Q33573126 | ||
Cardiac Home Education and Support Trial (CHEST): a pilot study | Q33595923 | ||
Benzodiazepines, Z-drugs and the risk of hip fracture: A systematic review and meta-analysis | Q33610208 | ||
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium | Q33869820 | ||
The pedunculopontine nucleus: its role in the genesis of movement disorders | Q33921807 | ||
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial. | Q34018018 | ||
Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease | Q34135495 | ||
Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation | Q34206696 | ||
Cognitive impairment in multiple system atrophy: a position statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MODIMSA) study group | Q34245237 | ||
Therapeutic application of repetitive transcranial magnetic stimulation: a review | Q34311455 | ||
The impact of autonomic dysfunction on survival in patients with dementia with Lewy bodies and Parkinson's disease with dementia | Q34437544 | ||
Intravenous amantadine for freezing of gait resistant to dopaminergic therapy: a randomized, double-blind, placebo-controlled, cross-over clinical trial | Q34489770 | ||
MDS clinical diagnostic criteria for Parkinson's disease | Q34498274 | ||
Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study | Q34502926 | ||
Ophthalmological features of Parkinson disease | Q34548574 | ||
Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial | Q34743145 | ||
Clinical outcomes of progressive supranuclear palsy and multiple system atrophy | Q34767058 | ||
Nigral stimulation for resistant axial motor impairment in Parkinson's disease? A randomized controlled trial | Q34767779 | ||
Nonpharmacologic treatment of behavioral disturbance in dementia | Q34777695 | ||
Intervention strategies and risk-factor modification for falls prevention. A review of recent intervention studies. | Q34785734 | ||
Prediction of falls and/or near falls in people with mild Parkinson's disease | Q35031923 | ||
Trait impulsivity is associated with the risk of falls in Parkinson's disease | Q35114732 | ||
Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation | Q35456828 | ||
Subthalamic stimulation modulates cortical motor network activity and synchronization in Parkinson's disease | Q35533936 | ||
Effects of repetitive transcranial magnetic stimulation on motor symptoms in Parkinson disease: a systematic review and meta-analysis | Q35562138 | ||
Pharmacotherapy of dementia with Lewy bodies | Q35574995 | ||
Falls and health status in elderly women following first eye cataract surgery: a randomised controlled trial | Q35592777 | ||
Alpha oscillations in the pedunculopontine nucleus correlate with gait performance in parkinsonism | Q35706455 | ||
Multiple-system atrophy | Q38318175 | ||
Effects of orthostatic hypotension on cognition in Parkinson disease | Q38383989 | ||
The mechanisms of action of deep brain stimulation and ideas for the future development | Q38571273 | ||
Effects of deep brain stimulation on balance and gait in patients with Parkinson's disease: A systematic neurophysiological review | Q38576396 | ||
A home program of strength training, movement strategy training and education did not prevent falls in people with Parkinson's disease: a randomised trial | Q38739789 | ||
Virtual Reality for Gait Training: Can It Induce Motor Learning to Enhance Complex Walking and Reduce Fall Risk in Patients With Parkinson's Disease? | Q51894948 | ||
An 8-year prospective study of the relationship between cognitive performance and falling in very old adults. | Q51913615 | ||
Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias. | Q51925709 | ||
Rehabilitation treatment of gait in patients with Parkinson's disease with freezing: a comparison between two physical therapy protocols using visual and auditory cues with or without treadmill training. | Q51936673 | ||
Dual-tasking effects on gait variability: the role of aging, falls, and executive function. | Q51945707 | ||
Dementia with lewy bodies: findings from an international multicentre study. | Q51971473 | ||
Dual tasking, gait rhythmicity, and Parkinson's disease: which aspects of gait are attention demanding? | Q52038825 | ||
Neurotrophic factors in Parkinson's disease are regulated by exercise: Evidence-based practice. | Q38783594 | ||
A novel approach to falls classification in Parkinson's disease: development of the Fall-Related Activity Classification (FRAC). | Q38787870 | ||
Exercise-induced neuroprotective effects on neurodegenerative diseases: the key role of trophic factors. | Q38880082 | ||
Motor dual-tasking deficits predict falls in Parkinson's disease: A prospective study | Q38892463 | ||
Use of a Short-Form Balance Confidence Scale to Predict Future Recurrent Falls in People With Parkinson Disease | Q38969428 | ||
Effect of high-frequency subthalamic neurostimulation on gait and freezing of gait in Parkinson's disease: a systematic review and meta-analysis. | Q38987173 | ||
Low FAB score as a predictor of future falling in patients with Parkinson's disease: a 2.5-year prospective study | Q38995374 | ||
Subthalamic nucleus stimulation and gait in Parkinson's Disease: a not always fruitful relationship. | Q39028570 | ||
Long-term risk of falls in an incident Parkinson's disease cohort: the Norwegian ParkWest study. | Q39079510 | ||
Cognitive function, gait, and gait variability in older people: a population-based study | Q39120285 | ||
Impaired executive function can predict recurrent falls in Parkinson's disease. | Q39137139 | ||
Individual differences in brainstem and basal ganglia structure predict postural control and balance loss in young and older adults. | Q39163021 | ||
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up | Q39216879 | ||
The relative contribution of physical and cognitive fall risk factors in people with Parkinson's disease: a large prospective cohort study. | Q39313320 | ||
Intravenous amantadine on freezing of gait in Parkinson's disease: a randomized controlled trial | Q39346402 | ||
Dopaminergic Therapies for Non-motor Symptoms in Parkinson's Disease | Q39393248 | ||
Predicting first fall in newly diagnosed Parkinson's disease: Insights from a fall-naïve cohort | Q39398312 | ||
The mini-BESTest can predict parkinsonian recurrent fallers: a 6-month prospective study | Q39419091 | ||
Epidemiology, Diagnosis, and Management of Neurogenic Orthostatic Hypotension | Q39438327 | ||
Paired Studies Comparing Clinical Profiles of Lewy Body Dementia with Alzheimer's and Parkinson's Diseases. | Q39447026 | ||
Addition of a non-immersive virtual reality component to treadmill training to reduce fall risk in older adults (V-TIME): a randomised controlled trial | Q39490774 | ||
Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial | Q39665047 | ||
Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry | Q39830590 | ||
Predictors of future falls in Parkinson disease | Q39860695 | ||
Parkinsonian single fallers versus recurrent fallers: different fall characteristics and clinical features | Q39875586 | ||
Near-falls in people with Parkinson's disease: Circumstances, contributing factors and association with falling. | Q40063109 | ||
A meta-analysis of six prospective studies of falling in Parkinson's disease | Q40201100 | ||
Management of dementia-related behavioral disturbances: a nonpharmacologic approach | Q40368924 | ||
Balance, Body Motion, and Muscle Activity After High-Volume Short-Term Dance-Based Rehabilitation in Persons With Parkinson Disease: A Pilot Study | Q40401289 | ||
Disability is an Independent Predictor of Falls and Recurrent Falls in People with Parkinson's Disease Without a History of Falls: A One-Year Prospective Study. | Q40458623 | ||
Influence of urinary urgency and other urinary disturbances on falls in Parkinson's disease | Q41004949 | ||
Operational criteria for senile dementia of Lewy body type (SDLT) | Q41091449 | ||
The relationship between real world ambulatory activity and falls in incident Parkinson's disease: influence of classification scheme | Q41603606 | ||
Increased risk of Parkinson's disease in cataract patients: a population-based cohort study | Q41735653 | ||
Fall frequency, predicting falls and participating in falls research: similarities among people with Parkinson's disease with and without cognitive impairment. | Q41736123 | ||
Why do patients with Parkinson's disease fall? A cross-sectional analysis of possible causes of falls | Q41936290 | ||
Osteoporosis: A Hidden Nonmotor Face of Parkinson's Disease | Q42006032 | ||
Causes of death in multiple system atrophy | Q42765583 | ||
Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial | Q42930136 | ||
Preventing falls in elderly people | Q43204382 | ||
Risk factors for falls in community-dwelling patients with Alzheimer's disease and dementia with Lewy bodies: walking with visuocognitive impairment may cause a fall | Q43430786 | ||
Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study | Q43460562 | ||
Freezing of gait in PD: prospective assessment in the DATATOP cohort | Q43653453 | ||
One walk a year to 1000 within a year: continuous in-home unobtrusive gait assessment of older adults | Q35753959 | ||
Tai chi and postural stability in patients with Parkinson's disease. | Q35774528 | ||
Association between antidepressants and falls in Parkinson's disease. | Q35826600 | ||
External validation of a simple clinical tool used to predict falls in people with Parkinson disease | Q35875410 | ||
Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease | Q35944999 | ||
Exercise to prevent falls in older adults: an updated systematic review and meta-analysis. | Q36154257 | ||
Assessment of dual tasking has no clinical value for fall prediction in Parkinson’s disease | Q36205357 | ||
Differential Effects of Tango Versus Dance for PD in Parkinson Disease | Q36387726 | ||
Longitudinal falls data in Parkinson's disease: feasibility of fall diaries and effect of attrition | Q36390457 | ||
Medication and subthalamic nucleus deep brain stimulation similarly improve balance and complex gait in Parkinson disease | Q36428326 | ||
Parkinson's disease: pathophysiology | Q36495393 | ||
Levodopa Is a Double-Edged Sword for Balance and Gait in People With Parkinson's Disease | Q36585373 | ||
Treatment of delusions in dementia with Lewy bodies - response to pharmacotherapy. | Q36758947 | ||
Prevention of falls in older people with dementia | Q36844153 | ||
Efficacy of falls prevention interventions: protocol for a systematic review and network meta-analysis | Q36931666 | ||
Amantadine for freezing of gait in patients with Parkinson disease | Q36948725 | ||
Effectiveness of Non-Pharmacological Interventions to Prevent Falls in Older People: A Systematic Overview. The SENATOR Project ONTOP Series | Q37207475 | ||
Deep brain stimulation effect on freezing of gait | Q37231152 | ||
The clinical spectrum of freezing of gait in atypical parkinsonism | Q37231170 | ||
Droxidopa and Reduced Falls in a Trial of Parkinson Disease Patients With Neurogenic Orthostatic Hypotension | Q37265850 | ||
Diagnosis and the premotor phase of Parkinson disease | Q37394473 | ||
Effects of single-task versus dual-task training on balance performance in older adults: a double-blind, randomized controlled trial. | Q37400342 | ||
Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study | Q37401906 | ||
External validation of a 3-step falls prediction model in mild Parkinson's disease. | Q37416255 | ||
Multiple component interventions for preventing falls and fall-related injuries among older people: systematic review and meta-analysis | Q37591369 | ||
Recurrent falls and mortality in Parkinson's disease: a prospective two-year follow-up study | Q37764894 | ||
Risk factors for falls in community-dwelling older people: a systematic review and meta-analysis | Q37768322 | ||
Effectiveness and implementation aspects of interventions for preventing falls in elderly people in long-term care facilities: a systematic review of RCTs | Q37859460 | ||
The role of cognitive impairment in fall risk among older adults: a systematic review and meta-analysis | Q37989101 | ||
The management of orthostatic hypotension in Parkinson's disease. | Q38114882 | ||
Acute and chronic cognitive effects of levodopa and dopamine agonists on patients with Parkinson's disease: a review | Q38156172 | ||
New targets for deep brain stimulation treatment of Parkinson's disease | Q38161537 | ||
Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis | Q38211809 | ||
Prevention of falls in Parkinson's disease: a review of fall risk factors and the role of physical interventions. | Q38237222 | ||
Differences in clinical course between dementia with Lewy bodies and Alzheimer's disease | Q43911586 | ||
L-threo-3,4-dihydroxyphenylserine (L-DOPS) co-administered with entacapone improves freezing of gait in Parkinson's disease | Q44363017 | ||
Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study | Q44379328 | ||
Relationship between mild cognitive impairment and falls in older people with and without Parkinson's disease: 1-Year Prospective Cohort Study. | Q44655854 | ||
Autonomic dysfunction in dementia with Lewy bodies | Q44907900 | ||
A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa | Q45087241 | ||
Three simple clinical tests to accurately predict falls in people with Parkinson's disease. | Q45406230 | ||
Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies | Q46342133 | ||
Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial | Q46378100 | ||
Abolishing the 1-year rule: How much evidence will be enough? | Q46524557 | ||
Effects of methylphenidate on cognitive function and gait in patients with Parkinson's disease: a pilot study | Q46976250 | ||
Factors associated with falling in early, treated Parkinson's disease: The NET-PD LS1 cohort | Q47378765 | ||
Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative study | Q47612621 | ||
Falls in Parkinson's disease: A complex and evolving picture. | Q47631495 | ||
Causes of Death in Chinese Patients with Multiple System Atrophy | Q47639031 | ||
Motor performance differentiates individuals with Lewy body dementia, Parkinson's and Alzheimer's disease. | Q47905416 | ||
Low-frequency versus high-frequency stimulation of the pedunculopontine nucleus area in Parkinson's disease: a randomised controlled trial | Q48032945 | ||
A Randomized Controlled Trial to Reduce Falls in People With Parkinson's Disease | Q48053969 | ||
The impact of low-frequency stimulation of the pedunculopontine nucleus region on reaction time in parkinsonism | Q48159073 | ||
Repetitive transcranial stimulation for freezing of gait in Parkinson's disease | Q48160786 | ||
Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease | Q48177875 | ||
Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions? | Q48212198 | ||
Technology-assisted balance and gait training reduces falls in patients with Parkinson's disease: a randomized controlled trial with 12-month follow-up | Q48267273 | ||
Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. | Q48298885 | ||
Effect of Dual-Mode and Dual-Site Noninvasive Brain Stimulation on Freezing of Gait in Patients With Parkinson Disease | Q48311027 | ||
Spinal cord stimulation improves gait in patients with Parkinson's disease previously treated with deep brain stimulation | Q48424726 | ||
Unilateral pedunculopontine stimulation improves falls in Parkinson's disease | Q48428197 | ||
rCBF changes associated with PPN stimulation in a patient with Parkinson's disease: a PET study | Q48437496 | ||
Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease. | Q48452740 | ||
Impact of subthalamic nucleus stimulation on the initiation of gait in Parkinson's disease | Q48607520 | ||
Single session intermittent theta-burst stimulation on the left premotor cortex does not alleviate freezing of gait in Parkinson's disease | Q48692428 | ||
Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson's disease. | Q48705342 | ||
Transcranial direct current stimulation for treatment of freezing of gait: a cross-over study | Q48800103 | ||
Effects of bilateral subthalamic nucleus stimulation on parkinsonian gait | Q48813921 | ||
Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease | Q48831596 | ||
Postoperative gait deterioration after bilateral subthalamic nucleus stimulation in Parkinson's disease | Q48865419 | ||
Comparison of Self-report and Performance-Based Balance Measures for Predicting Recurrent Falls in People With Parkinson Disease: Cohort Study. | Q48875510 | ||
Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial | Q48957826 | ||
Natural history of falls in an incident cohort of Parkinson's disease: early evolution, risk and protective features. | Q49521363 | ||
Spinal cord stimulation therapy for gait dysfunction in advanced Parkinson's disease patients | Q50016031 | ||
Multitarget transcranial direct current stimulation for freezing of gait in Parkinson's disease | Q50047353 | ||
Association between abnormal nocturnal blood pressure profile and dementia in Parkinson's disease | Q50065397 | ||
Levodopa response in dementia with lewy bodies: a 1-year follow-up study. | Q50268234 | ||
Are the effects of community-based dance on Parkinson disease severity, balance, and functional mobility reduced with time? A 2-year prospective pilot study. | Q50635981 | ||
The incidence and risk factors of falls in Parkinson disease: prospective study. | Q50682382 | ||
Orthostatic hypotension, cerebral hypoperfusion, and visuospatial deficits in Lewy body disorders. | Q50690242 | ||
A model of free-living gait: A factor analysis in Parkinson's disease. | Q51046721 | ||
Reversible improvement in severe freezing of gait from Parkinson's disease with unilateral interleaved subthalamic brain stimulation. | Q51679511 | ||
Body-Fixed Sensors for Parkinson Disease. | Q51788877 | ||
Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study. | Q51875573 | ||
P921 | main subject | synucleinopathy | Q2376264 |
P304 | page(s) | 1-14 | |
P577 | publication date | 2019-08-27 | |
P1433 | published in | Canadian Journal of Neurological Sciences | Q5030246 |
P1476 | title | Falls in Synucleinopathies |
Search more.